Not_yet_recruitingNCT07502703

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community-Based Population in Semanan, Jakarta

Sponsor: Tarumanagara University

Trial Details

Condition	Dyslipidemia, Angina (Stable), Coronary Artery Disease (CAD), Heart Disease, Hypertension, Diabetes (DM)
Status	Not_yet_recruiting
Participants	300
Est. Completion	30 June 2026
Last Updated	20 Apr 2026

Primary Outcome

Agreement of rPPG-Derived Blood Pressure with Standard Measurements; Agreement of rPPG-Derived Heart Rate and Cardiac Workload; Concordance of rPPG-Based ASCVD Risk with Standard Risk Calculation; Concordance of rPPG-Derived Framingham Heart Age

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Adults aged ≥30 years 2. Willing to participate and provide informed consent 3. Able to undergo face scan, clinical examination, and laboratory testing Exclusion Criteria: 1. Facial abnormalities interfering with rPPG signal acquisition 2. Inability to remain still during measurement 3. Severe clinical instability 4. Incomplete key variables

Trial Sites

Countries

Indonesia

View Registry Entry

Related Analysis

Novel Contactless Cardiovascular Screening Trial: Remote Photoplethysmography vs Standard Clinical Measurements — Implications for Primary Care

Indonesian researchers are validating remote photoplethysmography (rPPG) technology that uses facial video analysis to measure cardiovascular parameters without contact. This 300-participant study could revolutionise cardiovascular screening accessibility in primary care settings.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service